Production (Stage)
Opus Genetics, Inc.
IRD
$1.04
$0.044.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -418.72% | -476.13% | -194.58% | -175.60% | -160.46% |
| Total Depreciation and Amortization | 360.00% | 66.67% | -25.00% | 0.00% | 25.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 451.69% | 502.17% | -28.67% | 33.66% | 117.46% |
| Change in Net Operating Assets | -23.97% | -24.19% | 201.26% | -523.44% | 176.34% |
| Cash from Operations | -806.79% | -2,200.00% | -158.75% | -152.98% | -118.90% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -28.32% | -51.42% | 50.89% | 876.36% | 264.47% |
| Repurchase of Common Stock | -73.81% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4,210.91% | 16.55% | -203.39% | -684.78% | -235.64% |
| Cash from Financing | 96.17% | -53.38% | 46.76% | 879.86% | 291.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -165.69% | -356.51% | -120.07% | -93.76% | -58.60% |